On this page

Ibuprofen

Prescription ANDA TE AB Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Ibuprofen
Generic name
Ibuprofen
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA
Labeler
Amneal Pharmaceuticals of New York LLC
Product type
Human Prescription Drug
DEA schedule
Not scheduled
Active ingredients
5
NDC product codes
172
Packages
718
Data completeness
83% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Ibuprofen 200 mg/1 310965 View
Ibuprofen 300 mg/1 310965 View
Ibuprofen 400 mg/1 310965 View
Ibuprofen 600 mg/1 310965 View
Ibuprofen 800 mg/1 310965 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Tablet
Route of administration
Oral
Presentations
400

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Anti-Inflammatory Agents EPC All 251 members
Cyclooxygenase Inhibitors [MoA] MoA All 251 members
Non-Steroidal [CS] CS All 251 members
Nonsteroidal Anti-inflammatory Drug [EPC] EPC All 251 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
213794
Application type
ANDA · Abbreviated New Drug Application
Approval date
May 8, 2020
Sponsor
AUROBINDO PHARMA LTD
Products on application
3
Submissions recorded
3
Products approved under application 213794.
Product Trade name Form Strength Ingredient Status TE Flags
213794-001 IBUPROFEN TABLET IBUPROFEN Prescription AB
213794-002 IBUPROFEN TABLET IBUPROFEN Prescription AB
213794-003 IBUPROFEN TABLET IBUPROFEN Prescription AB

Therapeutic equivalence

Source: Orange Book
TE code
AB
Reference Listed Drug
No
Reference Standard
No

What this rating means: Therapeutically equivalent — bioequivalence demonstrated by in vivo or in vitro testing

Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.

Approval history

Source: Drugs@FDA
Most recent submissions on application 213794.
Type No. Action Status Date Review
Supplement 5 Labeling Approved November 21, 2024 Standard
Supplement 2 Labeling Approved April 28, 2021 Standard
Original application 1 Approved May 8, 2020 Standard

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260604). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN OTC DRUG · 20260604 HUMAN OTC DRUG · 20251222 HUMAN OTC DRUG · 20250807 HUMAN PRESCRIPTION DRUG · 20250421

Boxed Warning

openFDA Drug Labeling

Cardiovascular Risk • NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk (See WARNINGS ). • Ibuprofen tablets are contraindicated for treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS ). Gastrointestinal Risk • NSAIDS cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events (see WARNINGS ).

Recent Major Changes

openFDA Drug Labeling

Dosage and Administration

Indications and Usage

openFDA Drug Labeling

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of Ibuprofen Tablets, USP and other treatment options before deciding to use Ibuprofen Tablets, USP. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Ibuprofen Tablets, USP are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Ibuprofen Tablets, USP are indicated for relief of mild to moderate pain. Ibuprofen Tablets, USP are also indicated for the treatment of primary dysmenorrhea. Controlled clinical trials to establish the safety and effectiveness of Ibuprofen Tablets, USP in children have not been conducted.

Purpose Pain Releiver / Fever Reducer nonsteroidal anti-inflammatory drug

Dosage and Administration

openFDA Drug Labeling

DOSAGE AND ADMINISTRATION Carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). After observing the response to initial therapy with ibuprofen tablets, the dose and frequency should be adjusted to suit an individual patient's needs. Do not exceed 3200 mg total daily dose. If gastrointestinal complaints occur, administer ibuprofen tablets with meals or milk. Rheumatoid arthritis and osteoarthritis, including flare-ups of chronic disease: Suggested Dosage: 1200 mg to 3200 mg daily (300 mg four times a day, 400 mg, 600 mg or 800 mg three times a day or four times a day). Individual patients may show a better response to 3200 mg daily, as compared with 2400 mg, although in well-controlled clinical trials patients on 3200 mg did not show a better mean response in terms of efficacy. Therefore, when treating patients with 3200 mg/day, the physician should observe sufficient increased clinical benefits to offset potential increased risk. The dose should be tailored to each patient and may be lowered or raised depending on the severity of symptoms either at time of initiating drug therapy or as the patient responds or fails to respond. In general, patients with rheumatoid arthritis seem to require higher doses of ibuprofen tablets than do patients with osteoarthritis. The smallest dose of ibuprofen tablets that yields acceptable control should be employed. A linear blood level dose-response relationship exists with single doses up to 800 mg (see CLINICAL PHARMACOLOGY for effects of food on rate of absorption). The availability of three tablet strengths facilitates dosage adjustment. In chronic conditions , a therapeutic response to therapy with ibuprofen tablets is some times seen in a few days to a week but most often is observed by two weeks. After a satisfactory response has been achieved, the patient's dose should be reviewed and adjusted as required. Mild to moderate pain: 400 mg every 4 to 6 hours as necessary for relief of pain. In controlled analgesic clinical trials, doses of ibuprofen tablets greater than 400 mg were no more effective than the 400 mg dose. Dysmenorrhea: For the treatment of dysmenorrhea, beginning with the earliest onset of such pain, ibuprofen tablets should be given in a dose of 400 mg every 4 hours as necessary for the relief of pain.

Contraindications

openFDA Drug Labeling

CONTRAINDICATIONS Ibuprofen tablets are contraindicated in patients with known hypersensitivity to Ibuprofen. Ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see WARNINGS, Anaphylactoid Reactions, and PRECAUTIONS, Preexisting Asthma ). Ibuprofen tablets are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS ).

Warnings and Cautions

openFDA Drug Labeling

Fetal Toxicity Inform pregnant women to avoid use of Ibuprofen and other NSAIDs starting at 30 weeks gestation because of the risk of the premature closing of the fetal ductus arteriosus. If treatment with Ibuprofen is needed for a pregnant woman between about 20 to 30 weeks gestation, advise her that she may need to be monitored for oligohydramnios, if treatment continues for longer than 48 hours [see WARNINGS ; Fetal Toxicity, PRECAUTIONS ; Pregnancy].

WARNINGS CARDIOVASCULAR EFFECTS Cardiovascular Thrombotic Events Clinical trials of several COX-2 selective and nonselective NSAIDs of up to three years duration have shown an increased risk of serious cardiovascular (CV) thrombotic events, including myocardial infarction (MI) and stroke, which can be fatal. Based on available data, it is unclear that the risk for CV thrombotic events is similar for all NSAIDs. The relative increase in serious CV thrombotic events over baseline conferred by NSAID use appears to be similar in those with and without known CV disease or risk factors for CV disease. However, patients with known CV disease or risk factors had a higher absolute incidence of excess serious CV thrombotic events, due to their increased baseline rate. Some observational studies found that this increased risk of serious CV thrombotic events began as early as the first weeks of treatment. The increase in CV thrombotic risk has been observed most consistently at higher doses. To minimize the potential risk for an adverse CV event in NSAID-treated patients, use the lowest effective dose for the shortest duration possible. Physicians and patients should remain alert for the development of such events, throughout the entire treatment course, even in the absence of previous CV symptoms. Patients should be informed about the symptoms of serious CV events and the steps to take if they occur. There is no consistent evidence that concurrent use of aspirin mitigates the increased risk of serious CV thrombotic events associated with NSAID use. The concurrent use of aspirin and an NSAID, such as ibuprofen, increases the risk of serious gastrointestinal (GI) events [see WARNINGS ]. Status Post Coronary Artery Bypass Graft (CABG) Surgery Two large, controlled clinical trials of a COX-2 selective NSAID for the treatment of pain in the first 10 to 14 days following CABG surgery found an increased incidence of myocardial infarction and stroke. NSAIDs are contraindicated in the setting of CABG [see CONTRAINDICATIONS ]. Post-MI Patients Observational studies conducted in the Danish National Registry have demonstrated that patients treated with NSAIDs in the post-MI period were at increased risk of reinfarction, CV-related death, and all-cause mortality beginning in the first week of treatment. In this same cohort, the incidence of death in the first year post MI was 20 per 100 person years in NSAID-treated patients compared to 12 per 100 person years in non-NSAID exposed patients. Although the absolute rate of death declined somewhat after the first year post-MI, the increased relative risk of death in NSAID users persisted over at least the next four years of follow-up. Avoid the use of ibuprofen tablets in patients with a recent MI unless the benefits are expected to outweigh the risk of recurrent CV thrombotic events. If ibuprofen tablets are used in patients with a recent MI, monitor patients for signs of cardiac ischemia. Hypertension NSAIDs including ibuprofen tablets can lead to onset of new hypertension or worsening of preexisting hypertension, either of which may contribute to the increased incidence of CV events. Patients taking thiazides or loop diuretics may have impaired response to these therapies when taking NSAIDs. NSAIDs, including ibuprofen tablets should be used with caution in patients with hypertension. Blood pressure (BP) should be monitored closely during the initiation of NSAID treatment and throughout the course of therapy. Heart Failure and Edema The Coxib and traditional NSAID Trialists’ Collaboration meta-analysis of randomized controlled trials demonstrated an approximately two-fold increase in hospitalizations for heart failure in COX-2 selective-treated patients and nonselective NSAID-treated patients compared to placebo-treated patients. In a Danish National Registry study of patients with heart failure, NSAID use increased the risk of MI, hospitalization for heart failure, and death. Additionally, fluid rete …

Do not use if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery Ask a doctor before use if ■ you have problems or serious side effects from taking pain relievers or fever reducers ■ the stomach bleeding warning applies to you ■ you have a history of stomach problems, such as heartburn ■ you have high blood pressure, heart disease, liver cirrhosis, or kidney disease ■ you have asthma ■ you are taking a diuretic Ask a doctor or pharmacist before use if you are ■ taking aspirin to prevent heart attack or stroke, because ibuprofen may decrease this benefit of aspirin under a doctor’s care for any serious condition ■ taking any other drug When using this product take with food or milk if stomach upset occursthe risk of heart attack or stroke may increase if you use more than directed or for longer than directed Stop use and ask a doctor if you experience any of the following signs of stomach bleeding:feel faint vomit blood have bloody or black stools have stomach pain that does not get better pain gets worse or lasts more than 10 days ■ fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear If pregnant or breast-feeding ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery

Ask a Doctor

openFDA Drug Labeling

Ask a doctor before use if ■ you have problems or serious side effects from taking pain relievers or fever reducers ■ the stomach bleeding warning applies to you ■ you have a history of stomach problems, such as heartburn ■ you have high blood pressure, heart disease, liver cirrhosis, or kidney disease ■ you have asthma ■ you are taking a diuretic Ask a doctor or pharmacist before use if you are ■ taking aspirin to prevent heart attack or stroke, because ibuprofen may decrease this benefit of aspirin under a doctor’s care for any serious condition ■ taking any other drug When using this product take with food or milk if stomach upset occursthe risk of heart attack or stroke may increase if you use more than directed or for longer than directed Stop use and ask a doctor if you experience any of the following signs of stomach bleeding:feel faint vomit blood have bloody or black stools have stomach pain that does not get better pain gets worse or lasts more than 10 days ■ fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear If pregnant or breast-feeding ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery

Ask a doctor before use if stomach bleeding warning applies to you you have problems or serious side effects from taking pain relievers or fever reducers you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic

Stop use and ask a doctor if you experience any of the following signs of stomach bleeding:feel faint vomit blood have bloody or black stools have stomach pain that does not get better pain gets worse or lasts more than 10 days ■ fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear If pregnant or breast-feeding ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery

Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing weakness in one part or side of body slurred speech leg swelling pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear

Adverse Reactions

openFDA Drug Labeling

ADVERSE REACTIONS The most frequent type of adverse reaction occurring with ibuprofen tablets is gastrointestinal. In controlled clinical trials the percentage of patients reporting one or more gastrointestinal complaints ranged from 4% to 16%. In controlled studies when ibuprofen tablets were compared to aspirin and indomethacin in equally effective doses, the overall incidence of gastrointestinal complaints was about half that seen in either the aspirin- or indomethacin-treated patients. Adverse reactions observed during controlled clinical trials at an incidence greater than 1% are listed in the table. Those reactions listed in Column one encompass observations in approximately 3,000 patients. More than 500 of these patients were treated for periods of at least 54 weeks. Still other reactions occurring less frequently than 1 in 100 were reported in controlled clinical trials and from marketing experience. These reactions have been divided into two categories: Column two of the table lists reactions with therapy with ibuprofen tablets where the probability of a causal relationship exists: for the reactions in Column three, a causal relationship with ibuprofen tablets has not been established. Reported side effects were higher at doses of 3200 mg/day than at doses of 2400 mg or less per day in clinical trials of patients with rheumatoid arthritis. The increases in incidence were slight and still within the ranges reported in the table. Incidence Greater Than 1% (but less than 3%) Probable Causal Relationship Precise Incidence Unknown (but less than 1%) Probable Causal Relationship** Precise Incidence Unknown (but less than 1%) Causal Relationship Unknown** GASTROINTESTINAL Nausea*, epigastric pain*, heartburn*, diarrhea, abdominal distress, nausea and vomiting, indigestion, constipation, abdominal cramps or pain, fullness of Gl tract (bloating and flatulence) Gastric or duodenal ulcer with bleeding and/or perforation, gastrointestinal hemorrhage, melena, gastritis, hepatitis, jaundice, abnormal liver function tests; pancreatitis CENTRAL NERVOUS SYSTEM Dizziness*, headache, nervousness Depression, insomnia, confusion, emotional liability, somnolence, aseptic meningitis with fever and coma [see PRECAUTIONS ] Paresthesias, hallucinations, dream abnormalities, pseudotumor cerebri DERMATOLOGIC Rash* (including maculopapular type), pruritus Vesiculobullous eruptions, urticaria, erythema multiforme, Stevens-Johnson syndrome, alopecia Toxic epidermal necrolysis, photoallergic skin reactions SPECIAL SENSES Tinnitus Hearing loss, amblyopia (blurred and/or diminished vision, scotomata and/or changes in color vision) [see PRECAUTIONS ] Conjunctivitis, diplopia, optic neuritis, cataracts HEMATOLOGIC Neutropenia, agranulocytosis, aplastic anemia, hemolytic anemia (sometimes Coombs positive), thrombocytopenia with or without purpura, eosinophilia, decreases in hemoglobin and hematocrit [see PRECAUTIONS ] Bleeding episodes (e.g., epistaxis, menorrhagia) METABOLIC/ENDOCRINE Decreased appetite Gynecomastia, hypoglycemic reaction, acidosis CARDIOVASCULAR Edema, fluid retention (generally responds promptly to drug discontinuation) [see PRECAUTIONS ] Congestive heart failure in patients with marginal cardiac function, elevated blood pressure, palpitations Arrhythmias (sinus tachycardia, sinus bradycardia) ALLERGIC Syndrome of abdominal pain, fever, chills, nausea and vomiting; anaphylaxis; bronchospasm [see CONTRAINDICATIONS ] Serum sickness, lupus erythematosus syndrome, Henoch-Schonlein vasculitis, angioedema RENAL Acute renal failure [see PRECAUTIONS ], decreased creatinine clearance, polyuria, azotemia, cystitis, hematuria Renal papillary necrosis MISCELLANEOUS Dry eyes and mouth, gingival ulcer, rhinitis tests * Reactions occurring in 3% to 9% of patients treated with ibuprofen tablets. (Those reactions occurring in less than 3% of the patients are unmarked.) ** Reactions are classified under “Probable Causal Relationship (PCR)” if there has …

Drug Interactions

openFDA Drug Labeling

Drug Interactions ACE-inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. Aspirin Pharmacodynamic studies have demonstrated interference with the antiplatelet activity of aspirin when ibuprofen 400 mg, given three times daily, is administered with enteric coated low-dose aspirin. The interaction exists even following a once-daily regimen of ibuprofen 400 mg, particularly when ibuprofen is dosed prior to aspirin. The interaction is alleviated if immediate-release low-dose aspirin is dosed at least 2 hours prior to a once daily regimen of ibuprofen; however, this finding cannot be extended to enteric-coated low-dose aspirin [see Clinical Pharmacology / Pharmacodynamics ]. Because there may be an increased risk of cardiovascular events due to the interference of ibuprofen with the antiplatelet effect of aspirin, for patients taking low-dose aspirin for cardio protection who require analgesics, consider use of an NSAID that does not interfere with the antiplatelet effect of aspirin, or non-NSAID analgesics, where appropriate. When ibuprofen tablets are administered with aspirin, its protein binding is reduced, although the clearance of free ibuprofen tablets is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential for increased adverse effects. Diuretics Clinical studies, as well as post marketing observations, have shown that ibuprofen tablets can reduce the natriuretic effect-of furosemide and thiazides in some patients. This response has been attributed to inhibition of renal prostaglandin synthesis. During concomitant therapy with NSAIDs, the patient should be observed closely for signs of renal failure (see WARNINGS , Renal Effects ), as well as to assure diuretic efficacy. Lithium Ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers. The mean minimum lithium concentration increased 15% and the renal clearance of lithium was decreased by 19% during this period of concomitant drug administration. This effect has been attributed to inhibition of renal prostaglandin synthesis by ibuprofen. Thus, when ibuprofen and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity. (Read circulars for lithium preparation before use of such concurrent therapy). Methotrexate NSAIDs have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices. This may indicate that they could enhance the toxicity of methotrexate. Caution should be used when NSAIDs are administered concomitantly with methotrexate. Warfarin-type anticoagulants Several short-term controlled studies failed to show that ibuprofen tablets significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on coumarin-type anticoagulants. However, because bleeding has been reported when ibuprofen tablets and other NSAIDs have been administered to patients on coumarin-type anticoagulants, the physician should be cautious when administering ibuprofen tablets to patients on anticoagulants. The effects of warfarin and NSAIDs on GI bleeding are synergistic, such that the users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone. H-2 Antagonists In studies with human volunteers, co-administration of cimetidine or ranitidine with ibuprofen had no substantive effect on ibuprofen serum concentrations.

Description

openFDA Drug Labeling

DESCRIPTION Ibuprofen tablets USP contain the active ingredient ibuprofen, which is (±) - 2 - ( p - isobutylphenyl) propionic acid. Ibuprofen is a white to off-white, crystalline powder with a melting point of 74 to 77°C and is very soluble in alcohol, in methanol, in acetone and in chloroform, slightly soluble in ethyl acetate, practically insoluble in water. The structural formula is represented below: Ibuprofen tablets USP, a nonsteroidal anti-inflammatory drug (NSAID), is available in 400 mg, 600 mg, and 800 mg tablets for oral administration. Inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol-part. hydrolyzed, povidone, stearic acid, talc and titanium dioxide. chemical Structure

Active Ingredient

openFDA Drug Labeling

Active ingredient (For Tablet) (in each tablet) Ibuprofen 200 mg (NSAID)* *nonsteroidal anti-inflammatory drug

Active ingredient (For Caplet) (in each caplet) Ibuprofen 200 mg (NSAID)* *nonsteroidal anti-inflammatory drug

OVERDOSAGE Approximately 11⁄2 hours after the reported ingestion of from 7 to 10 ibuprofen tablets (400 mg), a 19-month old child weighing 12 kg was seen in the hospital emergency room, apneic and cyanotic, responding only to painful stimuli. This type of stimulus, however, was sufficient to induce respiration. Oxygen and parenteral fluids were given; a greenish-yellow fluid was aspirated from the stomach with no evidence to indicate the presence of ibuprofen. Two hours after ingestion the child's condition seemed stable; she still responded only to painful stimuli and continued to have periods of apnea lasting from 5 to 10 seconds. She was admitted to intensive care and sodium bicarbonate was administered as well as infusions of dextrose and normal saline. By four hours post-ingestion she could be aroused easily, sit by herself and respond to spoken commands. Blood level of ibuprofen was 102.9 mcg/mL approximately 81⁄2 hours after accidental ingestion. At 12 hours she appeared to be completely recovered. In two other reported cases where children (each weighing approximately 10 kg) accidentally, acutely ingested approximately 120 mg/kg, there were no signs of acute intoxication or late sequelae. Blood level in one child 90 minutes after ingestion was 700 mcg/mL - about 10 times the peak levels seen in absorption-excretion studies. A 19-year old male who had taken 8,000 mg of ibuprofen over a period of a few hours complained of dizziness, and nystagmus was noted. After hospitalization, parenteral hydration and three days bed rest, he recovered with no reported sequelae. In cases of acute overdosage, the stomach should be emptied by vomiting or lavage, though little drug will likely be recovered if more than an hour has elapsed since ingestion. Because the drug is acidic and is excreted in the urine, it is theoretically beneficial to administer alkali and induce diuresis. In addition to supportive measures, the use of oral activated charcoal may help to reduce the absorption and reabsorption of ibuprofen tablets.

How Supplied / Storage and Handling

openFDA Drug Labeling

HOW SUPPLIED Ibuprofen tablets are available in the following strengths, colors and sizes: 800 mg (white, capsule shaped, film-coated tablets engraved “IBU” over “800” on one side) Bottles of 100 NDC 70512-780-10 Bottles of 500 NDC 70512-780-50. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Rx only Manufactured for: SOLA Pharmaceuticals Baton Rouge, LA 70810 Made in India Revised: 11/2024 Medication Guide for Nonsteroidal Anti-inflammatory Drugs (NSAIDs) What is the most important information I should know about medicines called Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)? NSAIDs can cause serious side effects, including: Increased risk of a heart attack or stroke that can lead to death. This risk may happen early in treatment and may increase: with increasing doses of NSAIDs with longer use of NSAIDs Do not take NSAIDs right before or after a heart surgery called a “coronary artery bypass graft (CABG).” Avoid taking NSAIDs after a recent heart attack, unless your healthcare provider tells you to. You may have an increased risk of another heart attack if you take NSAIDs after a recent heart attack. Increased risk of bleeding, ulcers, and tears (perforation) of the esophagus (tube leading from the mouth to the stomach), stomach and intestines: anytime during use without warning symptoms that may cause death The risk of getting an ulcer or bleeding increases with: past history of stomach ulcers, or stomach or intestinal bleeding with use of NSAIDs taking medicines called “corticosteroids”, “anticoagulants”, “SSRIs”, or “SNRIs” increasing doses of NSAIDs longer use of NSAIDs smoking drinking alcohol older age poor health advanced liver disease bleeding problems NSAIDs should only be used: exactly as prescribed at the lowest dose possible for your treatment for the shortest time needed What are NSAIDs? NSAIDs are used to treat pain and redness, swelling, and heat (inflammation) from medical conditions such as different types of arthritis, menstrual cramps, and other types of short-term pain. Who should not take NSAIDs? Do not take NSAIDs: if you have had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAIDs right before or after heart bypass surgery. Before taking NSAIDS, tell your healthcare provider about all of your medical conditions, including if you: have liver or kidney problems have high blood pressure have asthma are pregnant or plan to become pregnant. Taking NSAIDs at about 20 weeks of pregnancy or later may harm your unborn baby. If you need to take NSAIDs for more than 2 days when you are between 20 and 30 weeks of pregnancy, your healthcare provider may need to monitor the amount of fluid in your womb around your baby. You should not take NSAIDs after about 30 weeks of pregnancy. are breastfeeding or plan to breast feed. Tell your healthcare provider about all of the medicines you take, including prescription or over-the-counter medicines, vitamins or herbal supplements. NSAIDs and some other medicines can interact with each other and cause serious side effects. Do not start taking any new medicine without talking to your healthcare provider first. What are the possible side effects of NSAIDs? NSAIDs can cause serious side effects, including: See "What is the most important information I should know about medicines called Nonsteroidal Anti-inflammatory Drugs (NSAIDs)?" new or worse high blood pressure heart failure liver problems including liver failure kidney problems including kidney failure low red blood cells (anemia) life-threatening skin reactions life threatening allergic reactions Other side effects of NSAIDs include: stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness. Get emergency help right away if you get any of the following symptoms: shortness of breath or trouble breathing chest pain weakness in one part or side of your body slurred speech swelling of the face or throat Stop taking your NSAID and call your h …

Adverse event reports

Source: openFDA FAERS
283,546
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: IBUPROFEN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Recalls

Source: FDA Enforcement
Drug recall enforcement reports associated with this product.
Classification Reported Firm Reason Status
Class III November 27, 2024 Dr. Reddy's Laboratories, Inc. Failed Tablet/Capsule Specifications Ongoing
Class II September 4, 2024 Dr. Reddy's Laboratories, Inc. Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit. Ongoing
Class II September 4, 2024 Dr. Reddy's Laboratories, Inc. Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit. Ongoing
Class II September 4, 2024 Dr. Reddy's Laboratories, Inc. Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit. Ongoing
Class II June 15, 2022 Mckesson Medical-Surgical Inc. Corporate Office cGMP deviations: Temperature abuse Terminated
Class II January 31, 2018 Marksans Pharma Inc. CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies. Terminated
Class II January 31, 2018 Marksans Pharma Inc. CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies. Terminated
Class II September 25, 2013 Dr. Reddy's Laboratories, Inc. Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016. Terminated

Packaging and NDCs

Source: NDC Directory showing the first 400
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
50090-5433-0 50090-5433 A-S Medication Solutions 15 TABLET in 1 BOTTLE (50090-5433-0) July 17, 2025
50090-5433-1 50090-5433 A-S Medication Solutions 21 TABLET in 1 BOTTLE (50090-5433-1) January 18, 2021
50090-5433-4 50090-5433 A-S Medication Solutions 28 TABLET in 1 BOTTLE (50090-5433-4) January 18, 2021
50090-5433-5 50090-5433 A-S Medication Solutions 90 TABLET in 1 BOTTLE (50090-5433-5) January 18, 2021
50090-5435-0 50090-5435 A-S Medication Solutions 10 TABLET in 1 BOTTLE (50090-5435-0) January 18, 2021
50090-5435-2 50090-5435 A-S Medication Solutions 16 TABLET in 1 BOTTLE (50090-5435-2) January 18, 2021
50090-5435-3 50090-5435 A-S Medication Solutions 30 TABLET in 1 BOTTLE (50090-5435-3) January 18, 2021
50090-5435-4 50090-5435 A-S Medication Solutions 60 TABLET in 1 BOTTLE (50090-5435-4) January 18, 2021
50090-5435-5 50090-5435 A-S Medication Solutions 100 TABLET in 1 BOTTLE (50090-5435-5) January 18, 2021
50090-5435-7 50090-5435 A-S Medication Solutions 40 TABLET in 1 BOTTLE (50090-5435-7) January 18, 2021
50090-5435-8 50090-5435 A-S Medication Solutions 20 TABLET in 1 BOTTLE (50090-5435-8) January 18, 2021
50090-5435-9 50090-5435 A-S Medication Solutions 24 TABLET in 1 BOTTLE (50090-5435-9) January 18, 2021
50090-5444-4 50090-5444 A-S Medication Solutions 28 TABLET in 1 BOTTLE (50090-5444-4) January 22, 2021
50090-5444-5 50090-5444 A-S Medication Solutions 90 TABLET in 1 BOTTLE (50090-5444-5) January 22, 2021
50090-5444-7 50090-5444 A-S Medication Solutions 20 TABLET in 1 BOTTLE (50090-5444-7) January 22, 2021
50090-5445-0 50090-5445 A-S Medication Solutions 30 TABLET in 1 BOTTLE (50090-5445-0) January 22, 2021
50090-5446-0 50090-5446 A-S Medication Solutions 10 TABLET in 1 BOTTLE (50090-5446-0) January 22, 2021
50090-5446-2 50090-5446 A-S Medication Solutions 30 TABLET in 1 BOTTLE (50090-5446-2) January 22, 2021
50090-5446-3 50090-5446 A-S Medication Solutions 45 TABLET in 1 BOTTLE (50090-5446-3) May 17, 2024
50090-5446-4 50090-5446 A-S Medication Solutions 60 TABLET in 1 BOTTLE (50090-5446-4) January 22, 2021
50090-5446-5 50090-5446 A-S Medication Solutions 100 TABLET in 1 BOTTLE (50090-5446-5) January 22, 2021
50090-5446-7 50090-5446 A-S Medication Solutions 21 TABLET in 1 BOTTLE (50090-5446-7) January 22, 2021
50090-5446-8 50090-5446 A-S Medication Solutions 12 TABLET in 1 BOTTLE (50090-5446-8) January 22, 2021
50090-5446-9 50090-5446 A-S Medication Solutions 40 TABLET in 1 BOTTLE (50090-5446-9) January 22, 2021
50090-6616-0 50090-6616 A-S Medication Solutions 90 TABLET in 1 BOTTLE (50090-6616-0) August 24, 2023
50090-6676-0 50090-6676 A-S Medication Solutions 16 TABLET in 1 BOTTLE (50090-6676-0) September 5, 2023
50090-6676-1 50090-6676 A-S Medication Solutions 30 TABLET in 1 BOTTLE (50090-6676-1) September 5, 2023
50090-6676-3 50090-6676 A-S Medication Solutions 100 TABLET in 1 BOTTLE (50090-6676-3) September 5, 2023
50090-6676-4 50090-6676 A-S Medication Solutions 20 TABLET in 1 BOTTLE (50090-6676-4) September 5, 2023
50090-6676-8 50090-6676 A-S Medication Solutions 60 TABLET in 1 BOTTLE (50090-6676-8) September 5, 2023
50090-6677-0 50090-6677 A-S Medication Solutions 90 TABLET in 1 BOTTLE (50090-6677-0) September 5, 2023
50090-6677-2 50090-6677 A-S Medication Solutions 28 TABLET in 1 BOTTLE (50090-6677-2) September 5, 2023
50090-6886-0 50090-6886 A-S Medication Solutions 90 TABLET in 1 BOTTLE (50090-6886-0) December 6, 2023
80425-0047-1 80425-0047 Advanced Rx of Tennessee, LLC 90 TABLET in 1 BOTTLE (80425-0047-1) November 23, 2009
80425-0047-2 80425-0047 Advanced Rx of Tennessee, LLC 120 TABLET in 1 BOTTLE (80425-0047-2) November 23, 2009
80425-0047-3 80425-0047 Advanced Rx of Tennessee, LLC 60 TABLET in 1 BOTTLE (80425-0047-3) November 23, 2009
80425-0047-4 80425-0047 Advanced Rx of Tennessee, LLC 30 TABLET in 1 BOTTLE (80425-0047-4) November 23, 2009
80425-0047-5 80425-0047 Advanced Rx of Tennessee, LLC 100 TABLET in 1 BOTTLE (80425-0047-5) November 23, 2009
80425-0393-1 80425-0393 Advanced Rx of Tennessee, LLC 30 TABLET in 1 BOTTLE (80425-0393-1) May 23, 2024
80425-0393-2 80425-0393 Advanced Rx of Tennessee, LLC 60 TABLET in 1 BOTTLE (80425-0393-2) May 23, 2024
80425-0393-3 80425-0393 Advanced Rx of Tennessee, LLC 90 TABLET in 1 BOTTLE (80425-0393-3) May 23, 2024
80425-0393-4 80425-0393 Advanced Rx of Tennessee, LLC 100 TABLET in 1 BOTTLE (80425-0393-4) May 23, 2024
80425-0393-5 80425-0393 Advanced Rx of Tennessee, LLC 120 TABLET in 1 BOTTLE (80425-0393-5) May 23, 2024
80425-0424-1 80425-0424 Advanced Rx of Tennessee, LLC 30 TABLET in 1 BOTTLE (80425-0424-1) August 1, 2024
80425-0424-2 80425-0424 Advanced Rx of Tennessee, LLC 60 TABLET in 1 BOTTLE (80425-0424-2) August 1, 2024
80425-0424-3 80425-0424 Advanced Rx of Tennessee, LLC 90 TABLET in 1 BOTTLE (80425-0424-3) August 1, 2024
80425-0424-4 80425-0424 Advanced Rx of Tennessee, LLC 100 TABLET in 1 BOTTLE (80425-0424-4) August 1, 2024
80425-0426-1 80425-0426 Advanced Rx of Tennessee, LLC 30 TABLET in 1 BOTTLE (80425-0426-1) August 6, 2024
80425-0426-2 80425-0426 Advanced Rx of Tennessee, LLC 60 TABLET in 1 BOTTLE (80425-0426-2) August 6, 2024
80425-0426-3 80425-0426 Advanced Rx of Tennessee, LLC 90 TABLET in 1 BOTTLE (80425-0426-3) August 6, 2024
80425-0426-4 80425-0426 Advanced Rx of Tennessee, LLC 100 TABLET in 1 BOTTLE (80425-0426-4) August 6, 2024
80425-0537-1 80425-0537 Advanced Rx of Tennessee, LLC 30 TABLET in 1 BOTTLE (80425-0537-1) August 5, 2025
80425-0537-2 80425-0537 Advanced Rx of Tennessee, LLC 60 TABLET in 1 BOTTLE (80425-0537-2) August 5, 2025
80425-0537-3 80425-0537 Advanced Rx of Tennessee, LLC 90 TABLET in 1 BOTTLE (80425-0537-3) August 5, 2025
80425-0537-4 80425-0537 Advanced Rx of Tennessee, LLC 100 TABLET in 1 BOTTLE (80425-0537-4) August 5, 2025
80425-0537-5 80425-0537 Advanced Rx of Tennessee, LLC 120 TABLET in 1 BOTTLE (80425-0537-5) August 5, 2025
69168-335-01 69168-335 Allegiant Health 100 TABLET in 1 BOX (69168-335-01) December 19, 2014
69168-335-03 69168-335 Allegiant Health 250 TABLET in 1 BOTTLE (69168-335-03) December 19, 2014
69168-335-30 69168-335 Allegiant Health 30 TABLET in 1 BOX (69168-335-30) December 19, 2014
69168-335-40 69168-335 Allegiant Health 40 TABLET in 1 BOX (69168-335-40) December 19, 2014
60687-446-01 60687-446 American Health Packaging 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-446-01) / 1 TABLET in 1 BLISTER PACK (60687-446-11) October 1, 2019
60687-457-01 60687-457 American Health Packaging 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-457-01) / 1 TABLET in 1 BLISTER PACK (60687-457-11) June 3, 2019
60687-468-01 60687-468 American Health Packaging 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-468-01) / 1 TABLET in 1 BLISTER PACK (60687-468-11) March 25, 2020
65162-464-03 65162-464 Amneal Pharmaceuticals LLC 30 TABLET in 1 BOTTLE (65162-464-03) November 23, 2009
65162-464-06 65162-464 Amneal Pharmaceuticals LLC 60 TABLET in 1 BOTTLE (65162-464-06) November 23, 2009
65162-464-09 65162-464 Amneal Pharmaceuticals LLC 90 TABLET in 1 BOTTLE (65162-464-09) November 23, 2009
65162-464-10 65162-464 Amneal Pharmaceuticals LLC 100 TABLET in 1 BOTTLE (65162-464-10) November 23, 2009
65162-464-50 65162-464 Amneal Pharmaceuticals LLC 500 TABLET in 1 BOTTLE (65162-464-50) November 23, 2009
65162-465-03 65162-465 Amneal Pharmaceuticals LLC 30 TABLET in 1 BOTTLE (65162-465-03) November 23, 2009
65162-465-05 65162-465 Amneal Pharmaceuticals LLC 50 TABLET in 1 BOTTLE (65162-465-05) November 23, 2009
65162-465-06 65162-465 Amneal Pharmaceuticals LLC 60 TABLET in 1 BOTTLE (65162-465-06) November 23, 2009
65162-465-09 65162-465 Amneal Pharmaceuticals LLC 90 TABLET in 1 BOTTLE (65162-465-09) November 23, 2009
65162-465-10 65162-465 Amneal Pharmaceuticals LLC 100 TABLET in 1 BOTTLE (65162-465-10) November 23, 2009
65162-465-50 65162-465 Amneal Pharmaceuticals LLC 500 TABLET in 1 BOTTLE (65162-465-50) November 23, 2009
65162-466-03 65162-466 Amneal Pharmaceuticals LLC 30 TABLET in 1 BOTTLE (65162-466-03) November 23, 2009
65162-466-05 65162-466 Amneal Pharmaceuticals LLC 50 TABLET in 1 BOTTLE (65162-466-05) November 23, 2009
65162-466-06 65162-466 Amneal Pharmaceuticals LLC 60 TABLET in 1 BOTTLE (65162-466-06) November 23, 2009
65162-466-09 65162-466 Amneal Pharmaceuticals LLC 90 TABLET in 1 BOTTLE (65162-466-09) November 23, 2009
65162-466-10 65162-466 Amneal Pharmaceuticals LLC 100 TABLET in 1 BOTTLE (65162-466-10) November 23, 2009
65162-466-50 65162-466 Amneal Pharmaceuticals LLC 500 TABLET in 1 BOTTLE (65162-466-50) November 23, 2009
53746-131-01 53746-131 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-131-01) January 5, 2009
53746-131-05 53746-131 Amneal Pharmaceuticals of New York LLC 500 TABLET in 1 BOTTLE (53746-131-05) January 5, 2009
53746-132-01 53746-132 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-132-01) January 5, 2009
53746-132-05 53746-132 Amneal Pharmaceuticals of New York LLC 500 TABLET in 1 BOTTLE (53746-132-05) January 5, 2009
53746-132-30 53746-132 Amneal Pharmaceuticals of New York LLC 30 TABLET in 1 BOTTLE (53746-132-30) January 5, 2009
53746-132-50 53746-132 Amneal Pharmaceuticals of New York LLC 50 TABLET in 1 BOTTLE (53746-132-50) January 5, 2009
53746-132-60 53746-132 Amneal Pharmaceuticals of New York LLC 60 TABLET in 1 BOTTLE (53746-132-60) January 5, 2009
53746-132-90 53746-132 Amneal Pharmaceuticals of New York LLC 90 TABLET in 1 BOTTLE (53746-132-90) January 5, 2009
53746-137-01 53746-137 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-137-01) January 5, 2009
53746-137-05 53746-137 Amneal Pharmaceuticals of New York LLC 500 TABLET in 1 BOTTLE (53746-137-05) January 5, 2009
53746-137-30 53746-137 Amneal Pharmaceuticals of New York LLC 30 TABLET in 1 BOTTLE (53746-137-30) January 5, 2009
53746-137-50 53746-137 Amneal Pharmaceuticals of New York LLC 50 TABLET in 1 BOTTLE (53746-137-50) January 5, 2009
53746-137-60 53746-137 Amneal Pharmaceuticals of New York LLC 60 TABLET in 1 BOTTLE (53746-137-60) January 5, 2009
53746-137-90 53746-137 Amneal Pharmaceuticals of New York LLC 90 TABLET in 1 BOTTLE (53746-137-90) January 5, 2009
53746-140-01 53746-140 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-140-01) December 16, 2009
53746-140-10 53746-140 Amneal Pharmaceuticals of New York LLC 1000 TABLET in 1 BOTTLE (53746-140-10) December 16, 2009
53746-140-24 53746-140 Amneal Pharmaceuticals of New York LLC 24 TABLET in 1 BOTTLE (53746-140-24) December 16, 2009
53746-142-01 53746-142 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-142-01) December 16, 2009
53746-142-10 53746-142 Amneal Pharmaceuticals of New York LLC 1000 TABLET in 1 BOTTLE (53746-142-10) December 16, 2009
53746-142-24 53746-142 Amneal Pharmaceuticals of New York LLC 24 TABLET in 1 BOTTLE (53746-142-24) December 16, 2009
53746-143-01 53746-143 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-143-01) December 16, 2009
53746-143-10 53746-143 Amneal Pharmaceuticals of New York LLC 1000 TABLET in 1 BOTTLE (53746-143-10) December 16, 2009
53746-143-24 53746-143 Amneal Pharmaceuticals of New York LLC 24 TABLET in 1 BOTTLE (53746-143-24) December 16, 2009
53746-144-01 53746-144 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-144-01) December 16, 2009
53746-144-10 53746-144 Amneal Pharmaceuticals of New York LLC 1000 TABLET in 1 BOTTLE (53746-144-10) December 16, 2009
53746-144-24 53746-144 Amneal Pharmaceuticals of New York LLC 24 TABLET in 1 BOTTLE (53746-144-24) December 16, 2009
53746-458-02 53746-458 Amneal Pharmaceuticals of New York LLC 250 TABLET in 1 BOTTLE (53746-458-02) April 30, 2013
53746-458-10 53746-458 Amneal Pharmaceuticals of New York LLC 1000 TABLET in 1 BOTTLE (53746-458-10) April 30, 2013
53746-460-02 53746-460 Amneal Pharmaceuticals of New York LLC 250 TABLET in 1 BOTTLE (53746-460-02) April 30, 2013
53746-460-10 53746-460 Amneal Pharmaceuticals of New York LLC 1000 TABLET in 1 BOTTLE (53746-460-10) April 30, 2013
53746-462-02 53746-462 Amneal Pharmaceuticals of New York LLC 250 TABLET in 1 BOTTLE (53746-462-02) April 30, 2013
53746-462-10 53746-462 Amneal Pharmaceuticals of New York LLC 1000 TABLET in 1 BOTTLE (53746-462-10) April 30, 2013
53746-464-01 53746-464 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-464-01) November 23, 2009
53746-464-05 53746-464 Amneal Pharmaceuticals of New York LLC 500 TABLET in 1 BOTTLE (53746-464-05) November 23, 2009
53746-464-30 53746-464 Amneal Pharmaceuticals of New York LLC 30 TABLET in 1 BOTTLE (53746-464-30) November 23, 2009
53746-464-60 53746-464 Amneal Pharmaceuticals of New York LLC 60 TABLET in 1 BOTTLE (53746-464-60) November 23, 2009
53746-464-90 53746-464 Amneal Pharmaceuticals of New York LLC 90 TABLET in 1 BOTTLE (53746-464-90) November 23, 2009
53746-465-01 53746-465 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-465-01) November 23, 2009
53746-465-05 53746-465 Amneal Pharmaceuticals of New York LLC 500 TABLET in 1 BOTTLE (53746-465-05) November 23, 2009
53746-465-30 53746-465 Amneal Pharmaceuticals of New York LLC 30 TABLET in 1 BOTTLE (53746-465-30) November 23, 2009
53746-465-50 53746-465 Amneal Pharmaceuticals of New York LLC 50 TABLET in 1 BOTTLE (53746-465-50) November 23, 2009
53746-465-60 53746-465 Amneal Pharmaceuticals of New York LLC 60 TABLET in 1 BOTTLE (53746-465-60) November 23, 2009
53746-465-90 53746-465 Amneal Pharmaceuticals of New York LLC 90 TABLET in 1 BOTTLE (53746-465-90) November 23, 2009
53746-466-01 53746-466 Amneal Pharmaceuticals of New York LLC 100 TABLET in 1 BOTTLE (53746-466-01) November 23, 2009
53746-466-05 53746-466 Amneal Pharmaceuticals of New York LLC 500 TABLET in 1 BOTTLE (53746-466-05) November 23, 2009
53746-466-30 53746-466 Amneal Pharmaceuticals of New York LLC 30 TABLET in 1 BOTTLE (53746-466-30) November 23, 2009
53746-466-50 53746-466 Amneal Pharmaceuticals of New York LLC 50 TABLET in 1 BOTTLE (53746-466-50) November 23, 2009
53746-466-60 53746-466 Amneal Pharmaceuticals of New York LLC 60 TABLET in 1 BOTTLE (53746-466-60) November 23, 2009
53746-466-90 53746-466 Amneal Pharmaceuticals of New York LLC 90 TABLET in 1 BOTTLE (53746-466-90) November 23, 2009
71610-891-53 71610-891 Aphena Pharma Solutions - Tennessee, LLC 60 TABLET in 1 BOTTLE (71610-891-53) March 28, 2025
71610-891-60 71610-891 Aphena Pharma Solutions - Tennessee, LLC 90 TABLET in 1 BOTTLE (71610-891-60) March 28, 2025
71610-891-70 71610-891 Aphena Pharma Solutions - Tennessee, LLC 120 TABLET in 1 BOTTLE (71610-891-70) March 28, 2025
71610-891-80 71610-891 Aphena Pharma Solutions - Tennessee, LLC 180 TABLET in 1 BOTTLE (71610-891-80) March 28, 2025
71610-891-92 71610-891 Aphena Pharma Solutions - Tennessee, LLC 270 TABLET in 1 BOTTLE (71610-891-92) March 28, 2025
71610-892-53 71610-892 Aphena Pharma Solutions - Tennessee, LLC 60 TABLET in 1 BOTTLE (71610-892-53) March 28, 2025
71610-892-60 71610-892 Aphena Pharma Solutions - Tennessee, LLC 90 TABLET in 1 BOTTLE (71610-892-60) March 28, 2025
71610-892-70 71610-892 Aphena Pharma Solutions - Tennessee, LLC 120 TABLET in 1 BOTTLE (71610-892-70) March 28, 2025
71610-892-80 71610-892 Aphena Pharma Solutions - Tennessee, LLC 180 TABLET in 1 BOTTLE (71610-892-80) March 28, 2025
71610-892-92 71610-892 Aphena Pharma Solutions - Tennessee, LLC 270 TABLET in 1 BOTTLE (71610-892-92) March 28, 2025
71610-897-53 71610-897 Aphena Pharma Solutions - Tennessee, LLC 60 TABLET in 1 BOTTLE (71610-897-53) April 2, 2025
71610-897-60 71610-897 Aphena Pharma Solutions - Tennessee, LLC 90 TABLET in 1 BOTTLE (71610-897-60) April 2, 2025
71610-897-70 71610-897 Aphena Pharma Solutions - Tennessee, LLC 120 TABLET in 1 BOTTLE (71610-897-70) April 2, 2025
71610-897-80 71610-897 Aphena Pharma Solutions - Tennessee, LLC 180 TABLET in 1 BOTTLE (71610-897-80) April 2, 2025
71610-897-92 71610-897 Aphena Pharma Solutions - Tennessee, LLC 270 TABLET in 1 BOTTLE (71610-897-92) April 2, 2025
71610-898-60 71610-898 Aphena Pharma Solutions - Tennessee, LLC 90 TABLET in 1 BOTTLE (71610-898-60) April 15, 2025
71610-898-70 71610-898 Aphena Pharma Solutions - Tennessee, LLC 120 TABLET in 1 BOTTLE (71610-898-70) April 15, 2025
71610-898-80 71610-898 Aphena Pharma Solutions - Tennessee, LLC 180 TABLET in 1 BOTTLE (71610-898-80) April 15, 2025
71610-898-92 71610-898 Aphena Pharma Solutions - Tennessee, LLC 270 TABLET in 1 BOTTLE (71610-898-92) April 15, 2025
71610-967-60 71610-967 Aphena Pharma Solutions - Tennessee, LLC 90 TABLET in 1 BOTTLE (71610-967-60) December 3, 2025
71610-967-80 71610-967 Aphena Pharma Solutions - Tennessee, LLC 180 TABLET in 1 BOTTLE (71610-967-80) December 3, 2025
71610-967-92 71610-967 Aphena Pharma Solutions - Tennessee, LLC 270 TABLET in 1 BOTTLE (71610-967-92) December 3, 2025
71610-968-53 71610-968 Aphena Pharma Solutions - Tennessee, LLC 60 TABLET in 1 BOTTLE (71610-968-53) February 20, 2026
71610-968-60 71610-968 Aphena Pharma Solutions - Tennessee, LLC 90 TABLET in 1 BOTTLE (71610-968-60) December 3, 2025
71610-968-80 71610-968 Aphena Pharma Solutions - Tennessee, LLC 180 TABLET in 1 BOTTLE (71610-968-80) December 3, 2025
71610-968-92 71610-968 Aphena Pharma Solutions - Tennessee, LLC 270 TABLET in 1 BOTTLE (71610-968-92) December 3, 2025
71610-969-60 71610-969 Aphena Pharma Solutions - Tennessee, LLC 90 TABLET in 1 BOTTLE (71610-969-60) December 3, 2025
71610-969-80 71610-969 Aphena Pharma Solutions - Tennessee, LLC 180 TABLET in 1 BOTTLE (71610-969-80) December 3, 2025
71610-969-92 71610-969 Aphena Pharma Solutions - Tennessee, LLC 270 TABLET in 1 BOTTLE (71610-969-92) December 3, 2025
76420-415-01 76420-415 Asclemed USA, Inc. 100 TABLET in 1 BOTTLE (76420-415-01) August 2, 2025
76420-415-05 76420-415 Asclemed USA, Inc. 500 TABLET in 1 BOTTLE (76420-415-05) August 2, 2025
76420-415-30 76420-415 Asclemed USA, Inc. 30 TABLET in 1 BOTTLE (76420-415-30) August 2, 2025
76420-415-60 76420-415 Asclemed USA, Inc. 60 TABLET in 1 BOTTLE (76420-415-60) August 2, 2025
76420-415-90 76420-415 Asclemed USA, Inc. 90 TABLET in 1 BOTTLE (76420-415-90) August 2, 2025
76420-575-01 76420-575 Asclemed USA, Inc. 100 TABLET in 1 BOTTLE (76420-575-01) July 20, 2023
76420-575-30 76420-575 Asclemed USA, Inc. 30 TABLET in 1 BOTTLE (76420-575-30) July 20, 2023
76420-575-60 76420-575 Asclemed USA, Inc. 60 TABLET in 1 BOTTLE (76420-575-60) July 20, 2023
76420-575-90 76420-575 Asclemed USA, Inc. 90 TABLET in 1 BOTTLE (76420-575-90) July 20, 2023
76420-576-01 76420-576 Asclemed USA, Inc. 100 TABLET in 1 BOTTLE (76420-576-01) July 20, 2023
76420-576-02 76420-576 Asclemed USA, Inc. 2 TABLET in 1 BOTTLE (76420-576-02) October 6, 2023
76420-576-05 76420-576 Asclemed USA, Inc. 500 TABLET in 1 BOTTLE (76420-576-05) October 6, 2023
76420-576-10 76420-576 Asclemed USA, Inc. 10 TABLET in 1 BOTTLE (76420-576-10) October 6, 2023
76420-576-20 76420-576 Asclemed USA, Inc. 20 TABLET in 1 BOTTLE (76420-576-20) October 6, 2023
76420-576-30 76420-576 Asclemed USA, Inc. 30 TABLET in 1 BOTTLE (76420-576-30) July 20, 2023
76420-576-60 76420-576 Asclemed USA, Inc. 60 TABLET in 1 BOTTLE (76420-576-60) July 20, 2023
76420-576-90 76420-576 Asclemed USA, Inc. 90 TABLET in 1 BOTTLE (76420-576-90) July 20, 2023
76420-577-01 76420-577 Asclemed USA, Inc. 100 TABLET in 1 BOTTLE (76420-577-01) July 20, 2023
76420-577-30 76420-577 Asclemed USA, Inc. 30 TABLET in 1 BOTTLE (76420-577-30) July 20, 2023
76420-577-60 76420-577 Asclemed USA, Inc. 60 TABLET in 1 BOTTLE (76420-577-60) July 20, 2023
76420-577-90 76420-577 Asclemed USA, Inc. 90 TABLET in 1 BOTTLE (76420-577-90) July 20, 2023
59651-075-22 59651-075 Aurobindo Pharma Limited 2000 TABLET in 1 BAG (59651-075-22) November 8, 2017
59651-078-26 59651-078 Aurobindo Pharma Limited 2500 TABLET in 1 BAG (59651-078-26) November 8, 2017
59651-360-01 59651-360 Aurobindo Pharma Limited 100 TABLET in 1 BOTTLE (59651-360-01) May 8, 2020
59651-360-05 59651-360 Aurobindo Pharma Limited 500 TABLET in 1 BOTTLE (59651-360-05) May 8, 2020
59651-360-23 59651-360 Aurobindo Pharma Limited 2100 TABLET in 1 BAG (59651-360-23) May 8, 2020
59651-361-01 59651-361 Aurobindo Pharma Limited 100 TABLET in 1 BOTTLE (59651-361-01) May 8, 2020
59651-361-05 59651-361 Aurobindo Pharma Limited 500 TABLET in 1 BOTTLE (59651-361-05) May 8, 2020
59651-361-22 59651-361 Aurobindo Pharma Limited 2000 TABLET in 1 BAG (59651-361-22) May 8, 2020
59651-362-01 59651-362 Aurobindo Pharma Limited 100 TABLET in 1 BOTTLE (59651-362-01) May 8, 2020
59651-362-05 59651-362 Aurobindo Pharma Limited 500 TABLET in 1 BOTTLE (59651-362-05) May 8, 2020
59651-362-10 59651-362 Aurobindo Pharma Limited 1100 TABLET in 1 BAG (59651-362-10) May 8, 2020
59651-676-26 59651-676 Aurobindo Pharma Limited 2500 TABLET in 1 BAG (59651-676-26) March 22, 2022
59651-677-22 59651-677 Aurobindo Pharma Limited 2000 TABLET in 1 BAG (59651-677-22) March 22, 2022
58602-708-01 58602-708 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-708-01) / 24 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-708-02 58602-708 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-708-02) / 100 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-708-03 58602-708 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-708-03) / 150 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-708-04 58602-708 Aurohealth LLC 200 TABLET in 1 BOTTLE, PLASTIC (58602-708-04) March 22, 2022
58602-708-05 58602-708 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-708-05) / 40 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-708-06 58602-708 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-708-06) / 90 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-708-07 58602-708 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-708-07) / 100 TABLET in 1 BOTTLE March 22, 2022
58602-708-08 58602-708 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-708-08) / 50 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-708-09 58602-708 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-708-09) / 50 TABLET in 1 BOTTLE March 22, 2022
58602-708-15 58602-708 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-708-15) / 60 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-708-17 58602-708 Aurohealth LLC 1000 TABLET in 1 BOTTLE (58602-708-17) December 25, 2024
58602-708-36 58602-708 Aurohealth LLC 250 TABLET in 1 BOTTLE, PLASTIC (58602-708-36) March 22, 2022
58602-708-40 58602-708 Aurohealth LLC 500 TABLET in 1 BOTTLE (58602-708-40) October 7, 2024
58602-708-41 58602-708 Aurohealth LLC 1000 TABLET in 1 BOTTLE, PLASTIC (58602-708-41) March 22, 2022
58602-708-49 58602-708 Aurohealth LLC 300 TABLET in 1 BOTTLE (58602-708-49) March 22, 2022
58602-708-52 58602-708 Aurohealth LLC 700 TABLET in 1 BOTTLE, PLASTIC (58602-708-52) March 22, 2022
58602-708-53 58602-708 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-708-53) / 150 TABLET in 1 BOTTLE March 22, 2022
58602-708-73 58602-708 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-708-73) / 24 TABLET in 1 BOTTLE March 22, 2022
58602-708-75 58602-708 Aurohealth LLC 300 TABLET in 1 BOTTLE, PLASTIC (58602-708-75) March 22, 2022
58602-708-79 58602-708 Aurohealth LLC 500 TABLET in 1 BOTTLE, PLASTIC (58602-708-79) May 15, 2024
58602-708-83 58602-708 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-708-83) / 200 TABLET in 1 BOTTLE March 22, 2022
58602-708-87 58602-708 Aurohealth LLC 550 TABLET in 1 BOTTLE, PLASTIC (58602-708-87) March 22, 2022
58602-713-01 58602-713 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-713-01) / 24 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-713-02 58602-713 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-713-02) / 100 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-713-03 58602-713 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-713-03) / 150 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-713-05 58602-713 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-713-05) / 40 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-713-06 58602-713 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-713-06) / 90 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-713-07 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-07) / 100 TABLET in 1 BOTTLE March 22, 2022
58602-713-08 58602-713 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-713-08) / 50 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-713-09 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-09) / 50 TABLET in 1 BOTTLE March 22, 2022
58602-713-10 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-10) / 60 TABLET in 1 BOTTLE March 22, 2022
58602-713-15 58602-713 Aurohealth LLC 1 BOTTLE, PLASTIC in 1 CARTON (58602-713-15) / 60 TABLET in 1 BOTTLE, PLASTIC March 22, 2022
58602-713-34 58602-713 Aurohealth LLC 200 TABLET in 1 BOTTLE, PLASTIC (58602-713-34) March 22, 2022
58602-713-36 58602-713 Aurohealth LLC 250 TABLET in 1 BOTTLE, PLASTIC (58602-713-36) March 22, 2022
58602-713-40 58602-713 Aurohealth LLC 500 TABLET in 1 BOTTLE, PLASTIC (58602-713-40) March 22, 2022
58602-713-41 58602-713 Aurohealth LLC 1000 TABLET in 1 BOTTLE, PLASTIC (58602-713-41) March 22, 2022
58602-713-45 58602-713 Aurohealth LLC 1500 TABLET in 1 BOTTLE (58602-713-45) March 22, 2022
58602-713-48 58602-713 Aurohealth LLC 500 TABLET in 1 BOTTLE (58602-713-48) March 22, 2022
58602-713-49 58602-713 Aurohealth LLC 300 TABLET in 1 BOTTLE (58602-713-49) March 22, 2022
58602-713-52 58602-713 Aurohealth LLC 700 TABLET in 1 BOTTLE, PLASTIC (58602-713-52) March 22, 2022
58602-713-53 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-53) / 150 TABLET in 1 BOTTLE March 22, 2022
58602-713-56 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-56) / 90 TABLET in 1 BOTTLE March 22, 2022
58602-713-57 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-57) / 40 TABLET in 1 BOTTLE March 22, 2022
58602-713-58 58602-713 Aurohealth LLC 1000 TABLET in 1 BOTTLE (58602-713-58) March 22, 2022
58602-713-59 58602-713 Aurohealth LLC 225 TABLET in 1 BOTTLE (58602-713-59) March 22, 2022
58602-713-63 58602-713 Aurohealth LLC 550 TABLET in 1 BOTTLE (58602-713-63) March 22, 2022
58602-713-71 58602-713 Aurohealth LLC 250 TABLET in 1 BOTTLE (58602-713-71) March 22, 2022
58602-713-73 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-73) / 24 TABLET in 1 BOTTLE March 22, 2022
58602-713-75 58602-713 Aurohealth LLC 300 TABLET in 1 BOTTLE, PLASTIC (58602-713-75) March 22, 2022
58602-713-83 58602-713 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-713-83) / 200 TABLET in 1 BOTTLE March 22, 2022
58602-713-86 58602-713 Aurohealth LLC 750 TABLET in 1 BOTTLE (58602-713-86) March 22, 2022
58602-713-87 58602-713 Aurohealth LLC 550 TABLET in 1 BOTTLE, PLASTIC (58602-713-87) March 22, 2022
58602-801-07 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-07) / 24 TABLET in 1 BOTTLE November 8, 2017
58602-801-12 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-12) / 40 TABLET in 1 BOTTLE November 8, 2017
58602-801-14 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-14) / 50 TABLET in 1 BOTTLE November 8, 2017
58602-801-15 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-15) / 60 TABLET in 1 BOTTLE November 8, 2017
58602-801-19 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-19) / 90 TABLET in 1 BOTTLE November 8, 2017
58602-801-21 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-21) / 100 TABLET in 1 BOTTLE November 8, 2017
58602-801-29 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-29) / 150 TABLET in 1 BOTTLE November 8, 2017
58602-801-34 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-34) / 200 TABLET in 1 BOTTLE November 8, 2017
58602-801-35 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-35) / 225 TABLET in 1 BOTTLE November 8, 2017
58602-801-36 58602-801 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-801-36) / 250 TABLET in 1 BOTTLE November 8, 2017
58602-801-38 58602-801 Aurohealth LLC 300 TABLET in 1 BOTTLE (58602-801-38) November 8, 2017
58602-801-40 58602-801 Aurohealth LLC 500 TABLET in 1 BOTTLE (58602-801-40) November 8, 2017
58602-801-41 58602-801 Aurohealth LLC 1000 TABLET in 1 BOTTLE (58602-801-41) November 8, 2017
58602-801-59 58602-801 Aurohealth LLC 1500 TABLET in 1 BOTTLE (58602-801-59) November 8, 2017
58602-801-87 58602-801 Aurohealth LLC 550 TABLET in 1 BOTTLE (58602-801-87) November 8, 2017
58602-801-88 58602-801 Aurohealth LLC 750 TABLET in 1 BOTTLE (58602-801-88) November 8, 2017
58602-802-07 58602-802 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-802-07) / 24 TABLET in 1 BOTTLE November 8, 2017
58602-802-14 58602-802 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-802-14) / 50 TABLET in 1 BOTTLE November 8, 2017
58602-802-21 58602-802 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-802-21) / 100 TABLET in 1 BOTTLE November 8, 2017
58602-802-29 58602-802 Aurohealth LLC 1 BOTTLE in 1 CARTON (58602-802-29) / 150 TABLET in 1 BOTTLE November 8, 2017
58602-802-34 58602-802 Aurohealth LLC 200 TABLET in 1 BOTTLE (58602-802-34) November 8, 2017
58602-802-38 58602-802 Aurohealth LLC 300 TABLET in 1 BOTTLE (58602-802-38) November 8, 2017
21130-396-05 21130-396 BETTER LIVING BRANDS LLC. 50 TABLET in 1 BOTTLE (21130-396-05) July 12, 2019
21130-396-25 21130-396 BETTER LIVING BRANDS LLC. 250 TABLET in 1 BOTTLE (21130-396-25) August 18, 2023
21130-006-01 21130-006 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-006-01) / 100 TABLET in 1 BOTTLE June 22, 2023
21130-006-05 21130-006 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-006-05) / 50 TABLET in 1 BOTTLE September 9, 2023
21130-006-42 21130-006 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-006-42) / 24 TABLET in 1 BOTTLE June 22, 2023
21130-006-53 21130-006 BETTER LIVING BRANDS, LLC 500 TABLET in 1 BOTTLE (21130-006-53) August 28, 2023
21130-261-01 21130-261 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-261-01) / 100 TABLET in 1 BOTTLE August 30, 2023
21130-261-05 21130-261 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-261-05) / 50 TABLET in 1 BOTTLE August 30, 2023
21130-261-42 21130-261 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-261-42) / 24 TABLET in 1 BOTTLE September 15, 2023
21130-261-53 21130-261 BETTER LIVING BRANDS, LLC 500 TABLET in 1 BOTTLE (21130-261-53) June 12, 2023
21130-261-54 21130-261 BETTER LIVING BRANDS, LLC 250 TABLET in 1 BOTTLE (21130-261-54) June 12, 2023
21130-261-56 21130-261 BETTER LIVING BRANDS, LLC 1000 TABLET in 1 BOTTLE (21130-261-56) June 22, 2023
21130-992-01 21130-992 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-992-01) / 100 TABLET in 1 BOTTLE August 8, 2023
21130-992-05 21130-992 BETTER LIVING BRANDS, LLC 1 BOTTLE in 1 CARTON (21130-992-05) / 50 TABLET in 1 BOTTLE August 8, 2023
21130-992-53 21130-992 BETTER LIVING BRANDS, LLC 500 TABLET in 1 BOTTLE (21130-992-53) August 8, 2023
37835-585-25 37835-585 BI-MART 250 TABLET in 1 BOTTLE (37835-585-25) February 1, 2025
0761-0908-04 0761-0908 Basic Drugs, Inc. 250 TABLET in 1 BOTTLE (0761-0908-04) December 15, 2021
37835-581-01 37835-581 Bi-Mart 100 TABLET in 1 BOTTLE (37835-581-01) February 1, 2025
37835-581-05 37835-581 Bi-Mart 500 TABLET in 1 BOTTLE (37835-581-05) February 1, 2025
37835-581-10 37835-581 Bi-Mart 1000 TABLET in 1 BOTTLE (37835-581-10) February 1, 2025
37835-581-25 37835-581 Bi-Mart 250 TABLET in 1 BOTTLE (37835-581-25) February 1, 2025
83209-464-09 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 9 TABLET in 1 BLISTER PACK (83209-464-09) June 3, 2024
83209-464-10 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 10 TABLET in 1 BLISTER PACK (83209-464-10) June 3, 2024
83209-464-12 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 12 TABLET in 1 BLISTER PACK (83209-464-12) June 3, 2024
83209-464-14 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 14 TABLET in 1 BLISTER PACK (83209-464-14) June 3, 2024
83209-464-15 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 15 TABLET in 1 BLISTER PACK (83209-464-15) June 3, 2024
83209-464-18 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 18 TABLET in 1 BLISTER PACK (83209-464-18) June 3, 2024
83209-464-20 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 20 TABLET in 1 BLISTER PACK (83209-464-20) June 3, 2024
83209-464-21 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 21 TABLET in 1 BLISTER PACK (83209-464-21) June 3, 2024
83209-464-24 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 24 TABLET in 1 BLISTER PACK (83209-464-24) June 3, 2024
83209-464-28 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 28 TABLET in 1 BLISTER PACK (83209-464-28) June 3, 2024
83209-464-30 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 30 TABLET in 1 BLISTER PACK (83209-464-30) June 3, 2024
83209-464-40 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 40 TABLET in 1 BLISTER PACK (83209-464-40) June 3, 2024
83209-464-60 83209-464 Boswell Pharmacy Services LLC d/b/a BPS Wholesale 60 TABLET in 1 BLISTER PACK (83209-464-60) June 3, 2024
63629-1468-1 63629-1468 Bryant Ranch Prepack 20 TABLET in 1 BOTTLE (63629-1468-1) October 27, 2011
63629-1468-2 63629-1468 Bryant Ranch Prepack 30 TABLET in 1 BOTTLE (63629-1468-2) October 29, 2024
63629-1468-3 63629-1468 Bryant Ranch Prepack 40 TABLET in 1 BOTTLE (63629-1468-3) October 29, 2024
63629-1468-4 63629-1468 Bryant Ranch Prepack 60 TABLET in 1 BOTTLE (63629-1468-4) October 29, 2024
63629-1468-5 63629-1468 Bryant Ranch Prepack 90 TABLET in 1 BOTTLE (63629-1468-5) April 29, 2011
63629-1468-6 63629-1468 Bryant Ranch Prepack 120 TABLET in 1 BOTTLE (63629-1468-6) September 26, 2012
63629-1468-7 63629-1468 Bryant Ranch Prepack 100 TABLET in 1 BOTTLE (63629-1468-7) January 21, 2011
63629-1468-8 63629-1468 Bryant Ranch Prepack 21 TABLET in 1 BOTTLE (63629-1468-8) January 10, 2012
63629-1468-9 63629-1468 Bryant Ranch Prepack 15 TABLET in 1 BOTTLE (63629-1468-9) December 4, 2013
63629-1470-0 63629-1470 Bryant Ranch Prepack 84 TABLET in 1 BOTTLE (63629-1470-0) March 2, 2010
63629-1470-1 63629-1470 Bryant Ranch Prepack 20 TABLET in 1 BOTTLE (63629-1470-1) December 21, 2021
63629-1470-2 63629-1470 Bryant Ranch Prepack 42 TABLET in 1 BOTTLE (63629-1470-2) May 8, 2018
63629-1470-3 63629-1470 Bryant Ranch Prepack 40 TABLET in 1 BOTTLE (63629-1470-3) December 21, 2021
63629-1470-4 63629-1470 Bryant Ranch Prepack 21 TABLET in 1 BOTTLE (63629-1470-4) December 21, 2021
63629-1470-5 63629-1470 Bryant Ranch Prepack 30 TABLET in 1 BOTTLE (63629-1470-5) December 21, 2021
63629-1470-6 63629-1470 Bryant Ranch Prepack 90 TABLET in 1 BOTTLE (63629-1470-6) December 21, 2021
63629-1470-7 63629-1470 Bryant Ranch Prepack 100 TABLET in 1 BOTTLE (63629-1470-7) December 21, 2021
63629-1470-8 63629-1470 Bryant Ranch Prepack 120 TABLET in 1 BOTTLE (63629-1470-8) December 21, 2021
63629-1470-9 63629-1470 Bryant Ranch Prepack 60 TABLET in 1 BOTTLE (63629-1470-9) December 21, 2021
71335-2682-1 71335-2682 Bryant Ranch Prepack 20 TABLET in 1 BOTTLE (71335-2682-1) September 17, 2025
71335-2682-2 71335-2682 Bryant Ranch Prepack 30 TABLET in 1 BOTTLE (71335-2682-2) September 17, 2025
71335-2682-3 71335-2682 Bryant Ranch Prepack 40 TABLET in 1 BOTTLE (71335-2682-3) September 17, 2025
71335-2682-4 71335-2682 Bryant Ranch Prepack 60 TABLET in 1 BOTTLE (71335-2682-4) September 17, 2025
71335-2682-5 71335-2682 Bryant Ranch Prepack 90 TABLET in 1 BOTTLE (71335-2682-5) September 17, 2025
71335-2682-6 71335-2682 Bryant Ranch Prepack 120 TABLET in 1 BOTTLE (71335-2682-6) September 17, 2025
71335-2682-7 71335-2682 Bryant Ranch Prepack 100 TABLET in 1 BOTTLE (71335-2682-7) September 17, 2025
71335-2682-8 71335-2682 Bryant Ranch Prepack 21 TABLET in 1 BOTTLE (71335-2682-8) September 17, 2025
71335-2682-9 71335-2682 Bryant Ranch Prepack 15 TABLET in 1 BOTTLE (71335-2682-9) September 17, 2025
71335-2683-0 71335-2683 Bryant Ranch Prepack 21 TABLET in 1 BOTTLE (71335-2683-0) September 17, 2025
71335-2683-1 71335-2683 Bryant Ranch Prepack 20 TABLET in 1 BOTTLE (71335-2683-1) September 17, 2025
71335-2683-2 71335-2683 Bryant Ranch Prepack 15 TABLET in 1 BOTTLE (71335-2683-2) September 17, 2025
71335-2683-3 71335-2683 Bryant Ranch Prepack 30 TABLET in 1 BOTTLE (71335-2683-3) September 17, 2025
71335-2683-4 71335-2683 Bryant Ranch Prepack 40 TABLET in 1 BOTTLE (71335-2683-4) September 17, 2025
71335-2683-5 71335-2683 Bryant Ranch Prepack 60 TABLET in 1 BOTTLE (71335-2683-5) September 17, 2025
71335-2683-6 71335-2683 Bryant Ranch Prepack 90 TABLET in 1 BOTTLE (71335-2683-6) September 17, 2025
71335-2683-7 71335-2683 Bryant Ranch Prepack 120 TABLET in 1 BOTTLE (71335-2683-7) September 17, 2025
71335-2683-8 71335-2683 Bryant Ranch Prepack 50 TABLET in 1 BOTTLE (71335-2683-8) September 17, 2025
71335-2683-9 71335-2683 Bryant Ranch Prepack 100 TABLET in 1 BOTTLE (71335-2683-9) September 17, 2025
71335-2689-0 71335-2689 Bryant Ranch Prepack 84 TABLET in 1 BOTTLE (71335-2689-0) September 18, 2025
71335-2689-1 71335-2689 Bryant Ranch Prepack 20 TABLET in 1 BOTTLE (71335-2689-1) September 18, 2025
71335-2689-2 71335-2689 Bryant Ranch Prepack 15 TABLET in 1 BOTTLE (71335-2689-2) September 18, 2025
71335-2689-3 71335-2689 Bryant Ranch Prepack 40 TABLET in 1 BOTTLE (71335-2689-3) September 18, 2025
71335-2689-4 71335-2689 Bryant Ranch Prepack 21 TABLET in 1 BOTTLE (71335-2689-4) September 18, 2025
71335-2689-5 71335-2689 Bryant Ranch Prepack 30 TABLET in 1 BOTTLE (71335-2689-5) September 18, 2025
71335-2689-6 71335-2689 Bryant Ranch Prepack 90 TABLET in 1 BOTTLE (71335-2689-6) September 18, 2025
71335-2689-7 71335-2689 Bryant Ranch Prepack 100 TABLET in 1 BOTTLE (71335-2689-7) September 18, 2025
71335-2689-8 71335-2689 Bryant Ranch Prepack 120 TABLET in 1 BOTTLE (71335-2689-8) September 18, 2025
71335-2689-9 71335-2689 Bryant Ranch Prepack 60 TABLET in 1 BOTTLE (71335-2689-9) September 18, 2025
70000-0597-1 70000-0597 CARDINAL HEALTH 1 BOTTLE in 1 CARTON (70000-0597-1) / 50 TABLET in 1 BOTTLE May 25, 2022
70000-0597-2 70000-0597 CARDINAL HEALTH 1 BOTTLE in 1 CARTON (70000-0597-2) / 100 TABLET in 1 BOTTLE May 25, 2022
51316-365-30 51316-365 CVS 300 TABLET in 1 BOTTLE (51316-365-30) May 25, 2024
69842-391-54 69842-391 CVS PHARMACY, INC. 15 POUCH in 1 CARTON (69842-391-54) / 2 TABLET in 1 POUCH November 9, 2017
69842-493-01 69842-493 CVS Pharmacy. Inc. 1 BOTTLE in 1 CARTON (69842-493-01) / 100 TABLET in 1 BOTTLE May 23, 2022
69842-493-53 69842-493 CVS Pharmacy. Inc. 500 TABLET in 1 BOTTLE (69842-493-53) May 23, 2022
55154-2583-0 55154-2583 Cardinal Health 107, LLC 10 BLISTER PACK in 1 BAG (55154-2583-0) / 1 TABLET in 1 BLISTER PACK July 10, 2026
10267-3846-2 10267-3846 Contract Pharmacal Corp. 250 TABLET in 1 BOTTLE (10267-3846-2) January 15, 2014
10267-3852-2 10267-3852 Contract Pharmacal Corp. 250 TABLET in 1 BOTTLE (10267-3852-2) January 15, 2014
10267-3909-2 10267-3909 Contract Pharmacal Corp. 250 TABLET in 1 BOTTLE (10267-3909-2) January 15, 2014
67046-1214-3 67046-1214 Coupler LLC 30 TABLET in 1 BLISTER PACK (67046-1214-3) April 27, 2026
72189-556-20 72189-556 Direct_Rx 20 TABLET in 1 BOTTLE (72189-556-20) June 11, 2024
72189-556-21 72189-556 Direct_Rx 21 TABLET in 1 BOTTLE (72189-556-21) June 11, 2024
72189-556-30 72189-556 Direct_Rx 30 TABLET in 1 BOTTLE (72189-556-30) June 11, 2024
72189-556-40 72189-556 Direct_Rx 40 TABLET in 1 BOTTLE (72189-556-40) June 11, 2024
72189-556-45 72189-556 Direct_Rx 45 TABLET in 1 BOTTLE (72189-556-45) June 11, 2024
72189-556-60 72189-556 Direct_Rx 60 TABLET in 1 BOTTLE (72189-556-60) June 11, 2024
72189-556-71 72189-556 Direct_Rx 100 TABLET in 1 BOTTLE (72189-556-71) June 11, 2024
72189-556-90 72189-556 Direct_Rx 90 TABLET in 1 BOTTLE (72189-556-90) June 11, 2024
72189-564-30 72189-564 Direct_rx 30 TABLET in 1 BOTTLE (72189-564-30) June 27, 2024
72189-564-60 72189-564 Direct_rx 60 TABLET in 1 BOTTLE (72189-564-60) June 27, 2024
75907-329-89 75907-329 Dr. Reddy's Laboratories Inc. 1500 TABLET in 1 POUCH (75907-329-89) September 26, 2025
75907-330-91 75907-330 Dr. Reddy's Laboratories Inc. 2000 TABLET in 1 POUCH (75907-330-91) September 26, 2025
75907-331-94 75907-331 Dr. Reddy's Laboratories Inc. 4000 TABLET in 1 POUCH (75907-331-94) September 26, 2025
55111-682-94 55111-682 Dr. Reddy's Laboratories Limited 4000 TABLET in 1 POUCH (55111-682-94) December 10, 2024
55111-683-91 55111-683 Dr. Reddy's Laboratories Limited 2000 TABLET in 1 POUCH (55111-683-91) December 10, 2024
55111-684-89 55111-684 Dr. Reddy's Laboratories Limited 1500 TABLET in 1 POUCH (55111-684-89) December 10, 2024
55319-366-25 55319-366 Family Dollar 250 TABLET in 1 BOTTLE (55319-366-25) November 1, 2023
51407-839-01 51407-839 Golden State Medical Supply, Inc. 100 TABLET in 1 BOTTLE (51407-839-01) September 26, 2025
51407-839-05 51407-839 Golden State Medical Supply, Inc. 500 TABLET in 1 BOTTLE (51407-839-05) September 26, 2025
51407-840-01 51407-840 Golden State Medical Supply, Inc. 100 TABLET in 1 BOTTLE (51407-840-01) September 26, 2025
51407-840-05 51407-840 Golden State Medical Supply, Inc. 500 TABLET in 1 BOTTLE (51407-840-05) September 26, 2025
51407-841-01 51407-841 Golden State Medical Supply, Inc. 100 TABLET in 1 BOTTLE (51407-841-01) September 26, 2025
51407-841-05 51407-841 Golden State Medical Supply, Inc. 500 TABLET in 1 BOTTLE (51407-841-05) September 26, 2025
62207-320-41 62207-320 Granules India Limited 24 TABLET in 1 BOTTLE (62207-320-41) November 14, 2019
62207-320-42 62207-320 Granules India Limited 50 TABLET in 1 BOTTLE (62207-320-42) November 14, 2019
62207-320-43 62207-320 Granules India Limited 100 TABLET in 1 BOTTLE (62207-320-43) November 14, 2019
62207-320-46 62207-320 Granules India Limited 250 TABLET in 1 BOTTLE (62207-320-46) November 14, 2019
62207-320-47 62207-320 Granules India Limited 500 TABLET in 1 BOTTLE (62207-320-47) November 14, 2019
62207-320-48 62207-320 Granules India Limited 750 TABLET in 1 BOTTLE (62207-320-48) November 14, 2019
62207-320-49 62207-320 Granules India Limited 1000 TABLET in 1 BOTTLE (62207-320-49) November 14, 2019
62207-320-89 62207-320 Granules India Limited 10 TABLET in 1 BOTTLE (62207-320-89) December 3, 2020
62207-320-90 62207-320 Granules India Limited 1700 TABLET in 1 BOTTLE (62207-320-90) December 3, 2020
62207-320-91 62207-320 Granules India Limited 160000 TABLET in 1 DRUM (62207-320-91) November 14, 2019
62207-321-41 62207-321 Granules India Limited 24 TABLET in 1 BOTTLE (62207-321-41) November 14, 2019
62207-321-42 62207-321 Granules India Limited 50 TABLET in 1 BOTTLE (62207-321-42) November 14, 2019
62207-321-43 62207-321 Granules India Limited 100 TABLET in 1 BOTTLE (62207-321-43) November 14, 2019
62207-321-46 62207-321 Granules India Limited 250 TABLET in 1 BOTTLE (62207-321-46) November 14, 2019
62207-321-47 62207-321 Granules India Limited 500 TABLET in 1 BOTTLE (62207-321-47) November 14, 2019
62207-321-48 62207-321 Granules India Limited 750 TABLET in 1 BOTTLE (62207-321-48) November 14, 2019
62207-321-49 62207-321 Granules India Limited 1000 TABLET in 1 BOTTLE (62207-321-49) November 14, 2019
62207-321-89 62207-321 Granules India Limited 10 TABLET in 1 BOTTLE (62207-321-89) December 3, 2020

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Orange Book FDA Therapeutic equivalence codes, reference drug flags, patents, exclusivity
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts
Enforcement FDA Recall records

Generated September 25, 2026 · 13 sections on this page.